Active Ingredient: INCLISIRAN SODIUM
Proprietary Name: LEQVIO
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: EQ 284MG BASE/1.5ML (EQ 189MG BASE/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N214012
Product Number: 001
Approval Date: Dec 22, 2021
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Prescription
Patent and Exclusivity Information